Drug Shortage Report for TEVA-VARENICLINE
| Report ID | 120262 |
| Drug Identification Number | 02426234 |
| Brand name | TEVA-VARENICLINE |
| Common or Proper name | VARENICLINE 1MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | VARENICLINE |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28 blister |
| ATC code | N07BA |
| ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2020-07-14 |
| Estimated end date | 2020-12-31 |
| Actual end date | 2020-08-03 |
| Shortage status | Resolved |
| Updated date | 2020-08-04 |
| Company comments | Allocating 100% of Teva market from July to Sept 2020 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-08-04 | French | Compare |
| v4 | 2020-08-04 | English | Compare |
| v3 | 2020-07-15 | English | Compare |
| v2 | 2020-07-14 | French | Compare |
| v1 | 2020-07-14 | English | Compare |
Showing 1 to 5 of 5